Introduction:Morphological peculiarities of liver after dexamethazonne influence on the mother-placenta-fetus system is not well studied.

Materials and Methods: The study included the livers of 144 white laboratory rats from 1 to 90 days of life. All animals were conditionally divided into 3 groups: Group I - intact animals, which were born from healthy rats without any dexamethazone administration during pregnancy; group II - control animals, which were exposed to antenatal intrafetal administration of 0.05 ml saline solution on the 18th day of prenatal development; group III - experimental animals, which were exposed to antenatal dexamethazone administration at 18th day of prenatal development. The absolute and relative mass of the liver was calculated. For light microscopy, sections were stained with hematoxylin and eosin. Detection of β-D-galactose carbohydrate residues was performed using a Lectin from Ricinus communis Agglutinin (RCA) by standard methods, using standard set of reagents "LectinTest" (Lviv). Quantitative and qualitative morphological characteristics of the liver were studied. Analysis of the obtained results was conducted by means of statistical methods with the use of computer license program «Statistica for Windows 13» (StatSoft Inc., № JPZ804I382130ARCN10-J).

Results: It was found that in rats after intrauterine administration of dexamethasone morphological changes in the liver are determined within three months after birth, which are manifested by changes in absolute and relative liver mass, as well as the rate of increase in absolute organ mass. The relations between hepatic membranes, vessels, connective tissue, cells of hematopoietic centers change. Changes in the cellular composition of the liver lobes are detected. The introduction of dexamethasone leads to changes in the formation of connective tissue in the liver, namely an increase in the amount of connective tissue in the long-term follow-up.

Conclusions: In rats after intrauterine administration of dexamethasone from the 14th to the 90th day there is an increase in the relative area occupied by connective tissue in the liver, reaching statistical significance on the 30th day. In animals after intrauterine administration of dexamethasone on the 1st day of life increases the absolute number of mononuclear hepatocytes in the central, and in the peripheral zone is detected. In the group of experimental animals, after intrauterine administration of dexamethasone there is a decrease in the relative area occupied by PAS-positive structures in the central zone from the 7th to the 21st day. In the peripheral zone, the decrease is more pronounced and is observed during the first three weeks after birth.

Keywords:Liver; Intranatal Dexamethazone Influence; Lymphocytes; PAS-Reaction

References

1. Althabe , et al. “A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: The ACT cluster-randomised trial”. Lancet 385.9968 (2015): 629-639.
2. Baruteau J., et al. “Transient Neonatal Liver Disease After Maternal Antenatal Intravenous Ig Infusions in Gestational Alloimmune Liver Disease Associated with Neonatal Haemochromatosis”. Journal of Pediatric Gastroenterology and Nutrition10 (2014): 1097.
3. Bogdanos D., et al. “Liver Immunology”. Comprehensive Physiology 3 (2013): 67-598.
4. Dancygier H. “The Liver as an Immune Organ”. In: Clinical Hepatology. Springer, Berlin, Heidelberg (2010).
5. De Vries A., et al. “Prenatal Dexamethasone exposure induces changes in nonhuman primate offspring cardiometabolic and hypothalamic pituitary-adrenal axis function”. Journal of Clinical Investigation 117 (2007): 1058-1067.
6. Eheim A., et al. “Immune cells and metabolic dysfunction”. Seminars in Immunopathology 36 (2014): 13-25.
7. Fasbender F., et al. “Natural Killer Cells and Liver Fibrosis”. Frontiers in Immunology 7 (2016): 19.
8. Fernandez-Balsells MM., et al. “Clinical review 1: adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis”. The Journal of Clinical Endocrinology and Metabolism 6 (2010): 2560-2575.
9. Ferris J., et al. “Estrogen and glucocorticoid receptor agonists and antagonists in oocytes modulate the pattern of expression of genes that encode nuclear receptor proteins in very early stage rainbow trout (Oncorhynchus mykiss) embryos”. Journal of Physiology and Biochemistry 41 (2015): 255-265.
10. Furukawa S., et al. “Histopathological findings of cleft palate in rat embryos induced by triamcinolone acetonide”. The Journal of Veterinary Medical Science 66 (2004): 397-402.
11. Gao B. “Basic liver immunology”. Cellular and Molecular Immunology3 (2016): 265-266.
12. Gao B., et al. “Liver: an organ with predominant innate immunity”. Hepatology2 (2008): 729-736.
13. Gur C., et al. “Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study”. Reproductive Toxicology 1 (2004): 93-101.
14. Hryhorieva O., et al. “Morphological Features of Liver Reactivity After Intranatal Antigen Influence”. Acta Scientific Gastrointestinal Disorders11 (2021): 72-83.
15. Ju C and Tacke F. “Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies”. Cellular and Molecular Immunology3 (2016): 316-327.
16. Kawada N. “The hepatic sinusoid ‘classic and contemporary’: a report on the 17th international symposium on cells ofthe hepatic sinusoid (ISCHS)”. Fibrogenesis Tissue Repair1 (2014): 2.
17. Kayhan B., et al. J “Immune Response in the Liver under Conditions of Infection, Malignancy, and Transplantation”. Padberg Journal of Immunology Research 2014 (2014): 2.
18. Kholodenko IV and Yarygin KN. “Cellular Mechanisms of Liver Regeneration and Cell-Based Therapies of Liver Diseases”. BioMed Research International 2017 (2017). 17.
19. Kim HK., et al. “Glucocorticoid receptor positively regulates transcription of FNDC5 in the liver”. Scientific Reports 7 (2017): 43296.
20. Knolle PA., et al. “The Liver as a Lymphoid Organ. Liver Immunology”. N.Y: Springer Science + Business Media (2014): 55-64.
21. Kovtun OP and Tsyvyan PB. “Premature Birth and Disease Programming. Contribution Of Neonatal Intensive Care”. Current Pediatrics5 (2014): 26-30.
22. Liaskou E., et al. “Innate Immune Cells in Liver Inflammation”. Mediators of Inflammation (2012): 21.
23. Lunghi L., et al. “Use of Glucocorticoids in Pregnancy”. Current Pharmaceutical Design 32 (2010): 3616-3637.
24. Manns Liver Immunology Principles and Practice/eds : M. E. Gershwin, J. M. Vierling M. P. 2^nd N.Y. : Springer Science + Business Media (2014): 480.
25. McKinlay C., et al. “Antenatal glucocorticoids: Where are we after forty years?”. Developmental Origins of Health and Disease 2 (2015): 127-142.
26. Meli R., et al. “Role of Innate Immune Response in Non-Alcoholic Fatty Liver Disease: Metabolic Complications and Therapeutic Tools”. Frontiers in Immunology 5 (2014): 177.
27. Nair S and Sigal LJ. “Changes in Natural Killer Cells in Aged Mice”. Handbook of Immunosenescence/eds. T. Fulop, C. Franceschi, K. Hirokawa, G. Pawelec. N.Y. : Springer, Cham (2019): 1-13.
28. Nyirenda MJ., et al. “Prenatal programming of metabolic syndrome in the common marmoset is associated with increased expression of 11 beta-hydroxysteroid dehydrogenase type 1”. Diabetes 58 (2009): 2873-2879.
29. O’Farrelly C. “Innate Immune Cells in the Liver”. In: Mackay I.R., Rose N.R., Diamond B., Davidson A. (eds) Encyclopedia of Medical Immunology. Springer, New York, NY (2014).
30. Robinson MW., et al. “Liver immunology and its role in inflammation and homeostasis”. Cellular and Molecular Immunology3 (2016): 267-276.
31. Sadri AR., et al. “Advances in Liver Regeneration: Revisiting Hepatic Stem/Progenitor Cells and Their Origin”. Stem Cells International 2016 (2016): 9.
32. Schümann J. and Kammüller M. “Hepatic Immune System”. Encyclopedia of Immunotoxicology/H. W. Vohr (eds). Berlin : Springer (2016).
33. Seckl J. R., Christen Y. “Hormones, intrauterine health and programming”. Springer International Publishing (2014): 198.
34. Seki S., et al. “New Findings about Liver Kupffer Cells/Macrophages, B Cells and their Functions”. Journal of Hepatitis Research 1 (2014): 1003.
35. Seki S., et al. “The Liver as a Pivotal Innate Immune Organ”. Immuno-Gastroenterology2 (2012): 76-89.
36. Shakil A., et al. “Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria”. Liver Transplant 16 (2000): 163-169.
37. Shuai Z., et al. “Adaptive immunity in liver”. Cellular and Molecular Immunology3 (2016): 354-368.
38. Solano ME., et al. “Antenatal endogenous and exogenous glucocorticoids and their impact on immune ontogeny and long-term immunity Semin”. Immunopathology 38 (2016): 739.
39. Tian Z., et al. “The Liver and Immune Tolerance. Liver Immunology”. /eds. M. Gershwin, J. Vierling, M. Manns. NY: Springer Science + Business Media (2014): 79-94.
40. Wohlleber D and Knolle P. “The Liver as an Immune-Privileged Site (2012).
41. Yokoyama , et al. “Tissue-resident natural killer cells”. Cold Spring Harbor Symposia on Quantitative Biology 78 (2013): 149-156.
42.  

Citation

Citation: Hryhorieva OA., et al. “Morphological Features of Liver Reactivity After Intranatal Dexamethazone Influence". Acta Scientific Gastrointestinal Disorders 5.5 (2022): 50-57-49.

Copyright

Copyright: © 2022 Hryhorieva OA., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.